Iris Life Solutions Profile
Key Indicators
- Authorised Capital ₹ 1.90 Cr
as on 25-07-2024
- Paid Up Capital ₹ 1.70 Cr
as on 25-07-2024
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
as on 25-07-2024
- Revenue 7.25%
(FY 2023)
- Profit 13.54%
(FY 2023)
- Ebitda 0.56%
(FY 2023)
- Net Worth 3.34%
(FY 2023)
- Total Assets 15.40%
(FY 2023)
About Iris Life Solutions
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.90 Cr and a paid-up capital of Rs 1.70 Cr.
The company currently has active open charges totaling ₹3.00 Cr.
Saraswathy Elangovan, Sujatha Jayavelu, and Elangovan Natarajan serve as directors at the Company.
- CIN/LLPIN
U24235KA2007PTC043386
- Company No.
043386
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2007
- Date of AGM
18 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Iris Life Solutions?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Elangovan Natarajan  | Managing Director | 01-Nov-2007 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saraswathy Elangovan | Whole-Time Director | 17-Jul-2007 | Current |
| Sujatha Jayavelu | Director | 17-Jul-2007 | Current |
Financial Performance of Iris Life Solutions.
Iris Life Solutions Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.25% increase. The company also saw a substantial improvement in profitability, with a 13.54% increase in profit. The company's net worth moved up by a moderate rise of 3.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iris Life Solutions?
In 2023, Iris Life Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Irides Life Wellness Solutions Private LimitedActive 6 years 11 monthsSaraswathy Elangovan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Mar 2022 | ₹3.00 Cr | Open |
How Many Employees Work at Iris Life Solutions?
Iris Life Solutions has a workforce of 16 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iris Life Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iris Life Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
